
JAK Inhibitors: Heart Risk Reassurance
Summary A recent European registry study showed no increased cardiovascular risk for rheumatoid arthritis patients using JAK inhibitors compared to other biologics, including TNF inhibitors. This contradicts previous concerns raised by the ORAL Surveillance trial. […]